177 related articles for article (PubMed ID: 29931323)
1. Human papillomavirus exposure and sexual behavior are significant risk factors for Barrett's dysplasia/esophageal adenocarcinoma.
Wong MYW; Wang B; Yang A; Khor A; Xuan W; Rajendra S
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29931323
[TBL] [Abstract][Full Text] [Related]
2. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.
Rajendra S; Wang B; Snow ET; Sharma P; Pavey D; Merrett N; Ball MJ; Brain T; Fernando R; Robertson IK
Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239
[TBL] [Abstract][Full Text] [Related]
3. Circulating human papillomavirus DNA detection in Barrett's dysplasia and esophageal adenocarcinoma.
Parameshwaran K; Sharma P; Rajendra S; Stelzer-Braid S; Xuan W; Rawlinson WD
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31313804
[TBL] [Abstract][Full Text] [Related]
4. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract][Full Text] [Related]
5. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
[TBL] [Abstract][Full Text] [Related]
6. Persistence of Human Papillomavirus, Overexpression of p53, and Outcomes of Patients After Endoscopic Ablation of Barrett's Esophagus.
Rajendra S; Wang B; Pavey D; Sharma P; Yang T; Lee CS; Gupta N; Ball MJ; Gill RS; Wu X
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1364-1368.e5. PubMed ID: 25460562
[TBL] [Abstract][Full Text] [Related]
7. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma.
Rajendra S; Xuan W; Hufnagel K; Sharma P; Pavey D; Alhajjiri N; Rattan A; Wang B
Ann N Y Acad Sci; 2020 Jun; 1470(1):44-56. PubMed ID: 32170783
[TBL] [Abstract][Full Text] [Related]
9. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
11. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
13. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
14. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
15. Viral load and integration status of high-risk human papillomaviruses in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
Wang B; Rajendra S; Pavey D; Sharma P; Merrett N; Wu X; Snow ET; Kumbhari V; Ball MJ; Robertson IK
Am J Gastroenterol; 2013 Nov; 108(11):1814-6. PubMed ID: 24192963
[No Abstract] [Full Text] [Related]
16. Human papillomavirus infection in Barrett's oesophagus in the UK: an infrequent event.
Rai N; Jenkins GJ; McAdam E; Hibbitts SJ; Fiander AN; Powell NG
J Clin Virol; 2008 Oct; 43(2):250-2. PubMed ID: 18718811
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus is detectable in Barrett's esophagus and esophageal carcinoma but is unlikely to be of any etiologic significance.
Iyer A; Rajendran V; Adamson CS; Peng Z; Cooper K; Evans MF
J Clin Virol; 2011 Mar; 50(3):205-8. PubMed ID: 21169053
[TBL] [Abstract][Full Text] [Related]
18. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
19. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens.
Antonsson A; Knight L; Whiteman DC;
Cancer Epidemiol; 2016 Apr; 41():96-8. PubMed ID: 26895084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
